Recombinant KIR2DL2 (Lirilumab Biosimilar) anticorps

N° du produit ABIN7491003

L’anticorps Human Monoclonal anti-KIR2DL2 (Lirilumab Biosimilar) a été validé pour FACS. Il convient pour détecter KIR2DL2 (Lirilumab Biosimilar) dans des échantillons de Humain.

Aperçu rapide pour Recombinant KIR2DL2 (Lirilumab Biosimilar) anticorps (ABIN7491003)

Antigène: KIR2DL2 (Lirilumab Biosimilar)

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Human

Clonalité: Monoclonal

Conjugué: Cet anticorp KIR2DL2 (Lirilumab Biosimilar) est non-conjugé

Application: Flow Cytometry (FACS)

Classe de qualité: Research Grade

Détail du produit anti-KIR2DL2 (Lirilumab Biosimilar) anticorps

Fonction: Anti-KIR2DL2 (lirilumab biosimilar) mAb

Attributs du produit: BMS-986015, IPH2102

Purification: Purified from cell culture supernatant by affinity chromatography

Isotype: IgG4

Information d'application

Indications d'application: Flow Cyt 1:100

Commentaires:

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Reconstitution: Reconstitute with deionized water

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Stock: -20 °C,-80 °C

Stockage commentaire: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Date de péremption: 12 months

Détails sur KIR2DL2 (Lirilumab Biosimilar)

Antigène: KIR2DL2 (Lirilumab Biosimilar)

Classe de substances: Biosimilar

Sujet: Synonyms: CD158b, CD158B1, NKAT-6, NKAT6, p58.2

UniProt: P43627